ARCHIVES

Olaparib Study Demonstrates No Changes In Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

September 24, 2004

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

In Brief: Cooperative Group Investigators Treat 10 For Every Patient In Protocols – Holland

October 31, 1975

In Brief: Wieand Named Director, Biostatistical Center For NSABP; LeMaistre Honored By AMA

June 30, 1995

Drug Combination Can Block Proteins Preventing Cell Death In Acute Lymphoblastic Leukemia

September 27, 2013

Symposium Planned On Grantmanship

April 20, 1984